Study of Bexxar Combined With External Beam Radiation Therapy
Status:
Terminated
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the response rate of patients with relapsed or
refractory low-grade or transformed low-grade, CD20-positive, B-cell non-Hodgkin's lymphoma
to Iodine-131 (I-131) tositumomab (Bexxar) therapy plus local palliative radiation therapy
(XRT).